BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 26377924)

  • 1. Normal tissue complication probability modeling for cochlea constraints to avoid causing tinnitus after head-and-neck intensity-modulated radiation therapy.
    Lee TF; Yeh SA; Chao PJ; Chang L; Chiu CL; Ting HM; Wang HY; Huang YJ
    Radiat Oncol; 2015 Sep; 10():194. PubMed ID: 26377924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of salivary flow and dose-volume modeling of complication incidence in patients with head-and-neck cancer receiving intensity-modulated radiotherapy.
    Marzi S; Iaccarino G; Pasciuti K; Soriani A; Benassi M; Arcangeli G; Giovinazzo G; Benassi M; Marucci L
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1252-9. PubMed ID: 19251097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: A planning comparative study.
    van der Laan HP; van de Water TA; van Herpt HE; Christianen ME; Bijl HP; Korevaar EW; Rasch CR; van 't Veld AA; van der Schaaf A; Schilstra C; Langendijk JA;
    Acta Oncol; 2013 Apr; 52(3):561-9. PubMed ID: 22708528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer.
    D'Avino V; Palma G; Liuzzi R; Conson M; Doria F; Salvatore M; Pacelli R; Cella L
    Radiat Oncol; 2015 Apr; 10():80. PubMed ID: 25890376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model-based calculation of thyroid gland normal tissue complication probability in head and neck cancer patients after radiation therapy.
    Kinclová I; Hajtmanová E; Matula P; Balentová S; Muríň P; Ďuroška M; Kozlíková K
    Strahlenther Onkol; 2020 Jun; 196(6):561-568. PubMed ID: 32016495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal tissue complication probability modeling of acute hematologic toxicity in patients treated with intensity-modulated radiation therapy for squamous cell carcinoma of the anal canal.
    Bazan JG; Luxton G; Mok EC; Koong AC; Chang DT
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):700-6. PubMed ID: 22414279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of Tomotherapy to spare the cochlea from excessive radiation in head and neck cancer.
    Nguyen NP; Smith-Raymond L; Vinh-Hung V; Sloan D; Davis R; Vos P; Abraham D; Stevie M; Krafft SP; Ly BH; Ries T; Karlsson U; Ceizyk M
    Oral Oncol; 2011 May; 47(5):414-9. PubMed ID: 21474364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal tissue complication probability modeling to guide individual treatment planning in pediatric cranial proton and photon radiotherapy.
    Dell'Oro M; Wilson P; Short M; Hua CH; Merchant TE; Bezak E
    Med Phys; 2022 Jan; 49(1):742-755. PubMed ID: 34796509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large cohort dose-volume response analysis of parotid gland function after radiotherapy: intensity-modulated versus conventional radiotherapy.
    Dijkema T; Terhaard CH; Roesink JM; Braam PM; van Gils CH; Moerland MA; Raaijmakers CP
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1101-9. PubMed ID: 18472355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlating planned radiation dose to the cochlea with primary site and tumor stage in patients with head and neck cancer treated with intensity-modulated radiation therapy.
    Zhang J; Qureshi MM; Kovalchuk N; Truong MT
    Med Dosim; 2014; 39(1):88-92. PubMed ID: 24485054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IMRT using simultaneously integrated boost (SIB) in head and neck cancer patients.
    Studer G; Huguenin PU; Davis JB; Kunz G; Lütolf UM; Glanzmann C
    Radiat Oncol; 2006 Mar; 1():7. PubMed ID: 16722599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
    Hitchcock YJ; Tward JD; Szabo A; Bentz BG; Shrieve DC
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):779-88. PubMed ID: 18707819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lyman-Kutcher-Burman NTCP model parameters for radiation pneumonitis and xerostomia based on combined analysis of published clinical data.
    Semenenko VA; Li XA
    Phys Med Biol; 2008 Feb; 53(3):737-55. PubMed ID: 18199912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal tissue complication probability estimation by the Lyman-Kutcher-Burman method does not accurately predict spinal cord tolerance to stereotactic radiosurgery.
    Daly ME; Luxton G; Choi CY; Gibbs IC; Chang SD; Adler JR; Soltys SG
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2025-32. PubMed ID: 21531516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analysis of normal tissue effects in the clinic (QUANTEC) guideline validation using quality of life questionnaire datasets for parotid gland constraints to avoid causing xerostomia during head-and-neck radiotherapy.
    Lee TF; Fang FM
    Radiother Oncol; 2013 Mar; 106(3):352-8. PubMed ID: 23333019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dependence of achievable plan quality on treatment technique and planning goal refinement: a head-and-neck intensity modulated radiation therapy application.
    Qi XS; Ruan D; Lee SP; Pham A; Kupelian P; Low DA; Steinberg M; Demarco J
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):817-24. PubMed ID: 25752396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicriteria optimization enables less experienced planners to efficiently produce high quality treatment plans in head and neck cancer radiotherapy.
    Kierkels RG; Visser R; Bijl HP; Langendijk JA; van 't Veld AA; Steenbakkers RJ; Korevaar EW
    Radiat Oncol; 2015 Apr; 10():87. PubMed ID: 25885444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoradionecrosis of the mandible: minimized risk profile following intensity-modulated radiation therapy (IMRT).
    Studer G; Studer SP; Zwahlen RA; Huguenin P; Grätz KW; Lütolf UM; Glanzmann C
    Strahlenther Onkol; 2006 May; 182(5):283-8. PubMed ID: 16673062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric predictors and Lyman normal tissue complication probability model of hematological toxicity in cervical cancer patients with treated with pelvic irradiation.
    Wang D; Yin Y; Zhou Q; Li Z; Ma X; Yin Y; Li B; Bai T; Li D; Zhu J
    Med Phys; 2022 Jan; 49(1):756-767. PubMed ID: 34800297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing 3DCRT and inversely optimized IMRT planning for head and neck cancer: equivalence between step-and-shoot and sliding window techniques.
    Longobardi B; De Martin E; Fiorino C; Dell'oca I; Broggi S; Cattaneo GM; Calandrino R
    Radiother Oncol; 2005 Nov; 77(2):148-56. PubMed ID: 16260056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.